Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

High protein intake can lead to serious hypophosphatemia and hypokalemia in growth restricted preterm newborns

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023698%3A_____%2F24%3AN0000048" target="_blank" >RIV/00023698:_____/24:N0000048 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/00216208:11120/24:43926318

  • Výsledek na webu

    <a href="https://doi.org/10.1002/jpr3.12029" target="_blank" >https://doi.org/10.1002/jpr3.12029</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1002/jpr3.12029" target="_blank" >10.1002/jpr3.12029</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    High protein intake can lead to serious hypophosphatemia and hypokalemia in growth restricted preterm newborns

  • Popis výsledku v původním jazyce

    Objectives High protein parenteral nutrition (HPPN) in the early postnatal period is a recommended strategy for very low birth weight (VLBW) infants. However, limited data is available on electrolyte changes when HPPN strategy is utilized. We investigated the impact of HPPN on the development of hypophosphatemia and hypokalemia in preterm VLBW newborns. Methods A retrospective, single-center study investigated the levels of phosphate and potassium in VLBW infants who received HPPN (amino acids intake up to 3.5 g/kg/day) during the first week of life. Preterm infants were divided into two subgroups: appropriate for gestational age (AGA) and small for gestational age (SGA) newborns. Clinical data were obtained from hospital database and medical records. Results Overall, 170 VLBW infants were included for the study analysis: 41 SGA (mean birth weight 752 +- 39 g) and 129 AGA infants (mean birth weight 994 +- 23 g). Phosphate and potassium levels were significantly lower in the SGA infants compared to AGA infants (Phosphate: 0.97 +- 0.07 mmol/l vs. 1.44 +- 0.04 mmol/l, p < 0.001; Potassium: 3.0 +- 0.1 mmol/l vs. 3.6 +- 0.1 mmol/l, p < 0.001). Conclusions Repeated measurement of serum phosphate and potassium is recommended when HPPN strategy is utilized in preterm SGA infants where significant hypophosphatemia and hypokalemia might have serious clinical consequences.

  • Název v anglickém jazyce

    High protein intake can lead to serious hypophosphatemia and hypokalemia in growth restricted preterm newborns

  • Popis výsledku anglicky

    Objectives High protein parenteral nutrition (HPPN) in the early postnatal period is a recommended strategy for very low birth weight (VLBW) infants. However, limited data is available on electrolyte changes when HPPN strategy is utilized. We investigated the impact of HPPN on the development of hypophosphatemia and hypokalemia in preterm VLBW newborns. Methods A retrospective, single-center study investigated the levels of phosphate and potassium in VLBW infants who received HPPN (amino acids intake up to 3.5 g/kg/day) during the first week of life. Preterm infants were divided into two subgroups: appropriate for gestational age (AGA) and small for gestational age (SGA) newborns. Clinical data were obtained from hospital database and medical records. Results Overall, 170 VLBW infants were included for the study analysis: 41 SGA (mean birth weight 752 +- 39 g) and 129 AGA infants (mean birth weight 994 +- 23 g). Phosphate and potassium levels were significantly lower in the SGA infants compared to AGA infants (Phosphate: 0.97 +- 0.07 mmol/l vs. 1.44 +- 0.04 mmol/l, p < 0.001; Potassium: 3.0 +- 0.1 mmol/l vs. 3.6 +- 0.1 mmol/l, p < 0.001). Conclusions Repeated measurement of serum phosphate and potassium is recommended when HPPN strategy is utilized in preterm SGA infants where significant hypophosphatemia and hypokalemia might have serious clinical consequences.

Klasifikace

  • Druh

    J<sub>ost</sub> - Ostatní články v recenzovaných periodicích

  • CEP obor

  • OECD FORD obor

    30209 - Paediatrics

Návaznosti výsledku

  • Projekt

  • Návaznosti

    V - Vyzkumna aktivita podporovana z jinych verejnych zdroju

Ostatní

  • Rok uplatnění

    2024

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    JPGN Reports

  • ISSN

    2691-171X

  • e-ISSN

    2691-171X

  • Svazek periodika

    5

  • Číslo periodika v rámci svazku

    1

  • Stát vydavatele periodika

    US - Spojené státy americké

  • Počet stran výsledku

    8

  • Strana od-do

    58-65

  • Kód UT WoS článku

  • EID výsledku v databázi Scopus